Articles
| Open Access |
https://doi.org/10.55640/
CONGENITAL HEART DEFECTS IN CHILDREN (LITERATURE REVIEW)
Odilova Shakhzoda Rustamovna,Tilavova Aziza Komilovna , Samarkand State Medical University, Samarkand, Uzbekistan.Abstract
Congenital heart defects (CHDs) represent one of the most significant challenges in pediatric cardiology and cardiovascular surgery worldwide [1]. According to the World Health Organization (WHO), the incidence of CHDs ranges from 8 to 12 per 1,000 live births [2]. In the structure of childhood mortality, cardiovascular pathology remains one of the leading causes, with CHDs accounting for 30–45% of all mortality associated with congenital developmental anomalies [3].
Keywords
References
Gurevich MA, Komissarova MS, Salikhova AO. Congenital heart defects in newborns: current issues and solutions. Pediatrics. 2019;98(7):15-21.
World Health Organization. Congenital anomalies. WHO fact sheets. 2021. Available at: https://www.who.int/news-room/fact-sheets/detail/congenital-anomalies (accessed 10.02.2025).
Kalinovsky GM, Sitnikov VG. Congenital heart defects in the structure of congenital anomalies in children. Issues of Modern Pediatrics. 2020;19(4):29-34.
Kolesov VI, Bockeria LA, Fadeev ME. Problems of diagnosis and surgical treatment of congenital heart defects in children in Russia. Russian Journal of Cardiology. 2021;26(5):7-15.
Kharchenko SL, Shkolnik EL, Efimova KA. Clinical and diagnostic characteristics of congenital heart defects in young children. Pediatrics named after G.N. Speransky. 2020;99(2):26-32.
Wilson NR, Devereux RB, Narula J. Genetics of Congenital Heart Disease: A Clinical Primer. J Am Coll Cardiol. 2018;72(19):2391-2405.
Nagornaya IF, Rodionova IA, Baskakova GA. Genetic aspects of congenital heart defects in children. Medical Genetics. 2019;18(3):43-49.
Zidere V, Miller O. Prenatal echocardiography: past, present and future. Arch Dis Child Fetal Neonatal Ed. 2020;105(2):193-197.
Funai T, Sato M, Nakamoto S, et al. Delayed presentation of congenital heart disease: current aspects of diagnosis and management. Pediatr Cardiol. 2019;40(8):1677-1685.
Deng J, Feng Y, Cao Y, et al. Fetal echocardiography in the diagnosis of congenital heart disease: A systematic review and meta-analysis. Medicine (Baltimore). 2021;100(18):e25513.
Kiselev VV, Zubarev PV, Mikhailova YG. Perinatal diagnosis of congenital heart defects: experience of a multidisciplinary center. Obstetrics and Gynecology. 2020;8(3):56-61.
Makarova VG, Kiryukhina EV. Modern ultrasound diagnostics of congenital heart defects in children: a literature review. Medical Imaging. 2021;25(2):41-49.
Gittenberger-de Groot AC, Jongbloed MRM, Galis E, et al. Morphological classification of congenital heart defects: the ongoing quest for clinically meaningful classification. Anatol J Cardiol. 2019;22(2):56-68.
Serov RA, Karaskin VM, Chumakov SV. Surgical tactics for the most common CHDs in children: literature review and experience of one center. Cardiology. 2021;61(1):18-27.
Ewer AK, Gardiner HM, Furmston AT, et al. Pulse oximetry screening and critical congenital heart disease. Lancet. 2021;398(10305):
Джураев Ж. Д., Абдукадирова Ш. Б., Мамаризаев И. К. HISTORICAL, CLINICAL, LABORATORY AND INSTRUMENTAL CHARACTERISTICS OF HEMORRHAGIC DISEASE OF NEWBORNS //УЗБЕКСКИЙ МЕДИЦИНСКИЙ ЖУРНАЛ. – 2024. – Т. 5. – №. 2.
Мамаризаев И. К. FEATURES OF THE COURSE, MORPHO-FUNCTIONAL AND CLINICAL-INSTRUMENTAL INDICATORS OF COMMUNITY-ACQUIRED PNEUMONIA WITH MYOCARDITIS IN CHILDREN //УЗБЕКСКИЙ МЕДИЦИНСКИЙ ЖУРНАЛ. – 2024. – Т. 5. – №. 2.
Мамаризаев И. К. ОПТИМИЗАЦИЯ ЛЕЧЕНИЯ АТОПИЧЕСКОГО ДЕРМАТИТА У ДЕТЕЙ //ILM FAN XABARNOMASI. – 2024. – Т. 1. – №. 2. – С. 320-325.
Komilzhonovich M. I. OPTIMIZATION OF TREATMENT OF ATOPIC DERMATITIS IN CHILDREN //International journal of scientific researchers (IJSR) INDEXING. – 2024. – Т. 5. – №. 2. – С. 642-646.
Мамаризаев И. К., Абдукадирова Ш. Б., Джураев Ж. Д. THE ROLE OF THE HEMOSTATIC SYSTEM IN THE DEVELOPMENT OF ACUTE OBSTRUCTIVE BRONCHITIS IN CHILDREN AGAINST THE BACKGROUND OF MYOCARDITIS //УЗБЕКСКИЙ МЕДИЦИНСКИЙ ЖУРНАЛ. – 2023. – Т. 4. – №. 5.
Каминский ВВ, Фишман МА. Критические врожденные пороки сердца: современные аспекты и перспективы лечения. Российский педиатрический журнал. 2022;25(5):12-19.
Franklin O, Burch M, Manning N, Sleap V, Macartney F. Prenatal diagnosis of congenital heart disease improves survival and reduces morbidity. Heart. 2018;104(9):673-679.
Sammour I, Sari T, Birk E, Zucker N, Rein AJ. Long-term outcome and risk factors for mortality after pediatric congenital heart surgery: a 15-year experience. Cardiol Young. 2019;29(4):489-498.
Семенова ЮП, Мамаев ДВ, Кузьмина НФ. Анализ коморбидной патологии у детей с врожденными пороками сердца. Педиатрия. 2021;100(2):64-69.
Габуния АИ, Турецкая АВ, Маторина НБ. Современные тенденции в диагностике и лечении врожденных пороков сердца: обзор. Российский вестник перинатологии и педиатрии. 2021;66(5):38-49.
Webb GD, Smallhorn JF, Therrien J. Congenital Heart Disease. In: Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. 11th ed. Philadelphia: Elsevier; 2019. p. 1683-1720.
Brown KL, Crowe S, Franklin RCG, et al. The impact of multidisciplinary care on outcomes in congenital heart disease. Eur J Cardiothorac Surg. 2020;58(2):241-248.
Hornberger LK, Sanders SP, Rein AJ, et al. Revised guidelines for the performance of fetal echocardiography. Ultrasound Obstet Gynecol. 2019;54(2):177-185.
Sifrim A, Hitz MP, Wilsdon A, et al. Interpreting secondary genetic findings in the pediatric population: congenital heart disease as a model. Genet Med. 2018;20(9):1048-1056.
Fogel MA, Jacobs ML, Norwood WI, et al. Cardiac MRI and CT: evaluation of congenital heart disease in children and adolescents. Circulation. 2018;137(10):1045-1060.
Mertens L, Helbing W, Sieverding L, et al. Expert consensus statements on the management of medication in pediatric heart failure. Cardiol Young. 2020;30(10):1430-1440.
Rosenthal D, Chrisant M, Edens E, Mahony L. The pediatric cardiomyopathy and heart failure: general considerations and current therapies. Prog Pediatr Cardiol. 2019;53:101-108.
Ohlsson A, Shah SS. Ibuprofen for the prevention of patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev. 2020;6(10):CD004213.
Кулаков ВВ, Летягина АВ, Степанова СВ. Эндоваскулярные методы лечения врожденных пороков сердца: клинический опыт одного центра. Кардиология. 2019;59(5):63-69.
McElhinney DB, Hornberger LK. Management of congenital heart disease in the newborn. Lancet. 2019;393(10173):161-174.
Kuijpers JM, Koolbergen DR, Groenink M, et al. Long-term outcomes of adult survivors of congenital heart disease. Eur Heart J. 2020;41(22):4161-4170.
Drzewiecka B, Królak-Olejnik B, Kalisiak B. The importance of folic acid in the prevention of congenital heart defects: a review. Dev Period Med. 2019;23(3):232-239.
Андреева ЕН, Ларина ВН, Сырейщикова ТЮ. Пренатальная эхокардиография и её значение в диагностике тяжёлых ВПС. Российский вестник акушера-гинеколога. 2021;21(6):44-50.
McBrien A, Kenny D. Multidisciplinary team management in congenital heart disease. Heart. 2020;106(9):681-686.
Исаева ДП, Дроздова ЮС, Бабенко ПВ. Психологическая адаптация детей с врожденными пороками сердца после оперативного лечения. Вопросы детской психологии. 2022;15(3):72-78.
Article Statistics
Downloads
Copyright License

This work is licensed under a Creative Commons Attribution 4.0 International License.